Home

Capital World Investors

CIK 1422849 · last filed 2025-11-18

Capital World Investors is a corporate insider who has filed 13 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for DBD, was dated Nov 18, 2025. Across all open-market trades the lifetime net is −$913.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $22.4M across reported positions. The firm reports its address in Los Angeles, CA. 15 SEC filings were submitted jointly with VERTEX PHARMACEUTICALS INC / MA.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22.39M

Companies

1

Total Filings

13

Lifetime Open-Market Net

-$913.0K

Filer Profile

Reported Address
333 SOUTH HOPE STREET
55TH FLOOR
LOS ANGELES, CA 90071
Phone
(213) 486-9200
State of Incorporation
DE
Related Filers
VERTEX PHARMACEUTICALS INC / MA — 15 joint filings, latest 2026-05-14
LOCKHEED MARTIN CORP — 14 joint filings, latest 2022-02-11
REGENERON PHARMACEUTICALS, INC. — 14 joint filings, latest 2024-02-09
Alteryx, Inc. — 11 joint filings, latest 2023-10-10
KLA TENCOR CORP — 11 joint filings, latest 2016-08-10
NOBLE ENERGY INC — 11 joint filings, latest 2018-08-10
NATURAL RESOURCES CO PIONEER — 11 joint filings, latest 2024-02-09
CO BOEING — 10 joint filings, latest 2026-05-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DBD 10%+ Owner 356,049 $62.88 $22.39M -$913.0K 13 2025-11-18

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-18 DBD Other (J) +20,180 $1.31M EDGAR
2025-03-03 DBD Sell (S) −19,842 -$866.1K EDGAR
2025-02-10 DBD Other (J) +13,897 $619.0K EDGAR
2024-04-05 DBD Sell (S) −184 -$6.1K EDGAR
2024-04-03 DBD Sell (S) −100 -$3.5K EDGAR
2024-04-01 DBD Sell (S) −200 -$6.9K EDGAR
2024-03-28 DBD Sell (S) −100 -$3.5K EDGAR
2024-03-11 DBD Sell (S) −100 -$3.3K EDGAR
2024-03-07 DBD Sell (S) −100 -$3.3K EDGAR
2024-03-05 DBD Sell (S) −100 -$3.3K EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.